Bio-Rad Laboratories (NYSE:BIO.B) Shares Gap Down – Here’s What Happened

Bio-Rad Laboratories, Inc. (NYSE:BIO.B)’s share price gapped down prior to trading on Tuesday . The stock had previously closed at $341.00, but opened at $310.00. Bio-Rad Laboratories shares last traded at $310.00, with a volume of 104 shares trading hands.

Bio-Rad Laboratories Price Performance

The company has a current ratio of 6.14, a quick ratio of 4.52 and a debt-to-equity ratio of 0.16. The business has a fifty day simple moving average of $334.05 and a 200 day simple moving average of $326.52. The stock has a market capitalization of $9.77 billion, a P/E ratio of -12.77 and a beta of 0.72.

Bio-Rad Laboratories (NYSE:BIO.B) last released its earnings results on Wednesday, October 30th. The company reported $2.01 earnings per share (EPS) for the quarter. The company had revenue of $649.73 million during the quarter. Bio-Rad Laboratories had a positive return on equity of 3.74% and a negative net margin of 30.18%.

About Bio-Rad Laboratories

Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.